Attached files

file filename
8-K/A - POSITIVEID Corpform8-ka.htm
EX-99.2 - POSITIVEID Corpex99-2.htm
EX-99.1 - POSITIVEID Corpex99-1.htm

 

Exhibit 99.3

 

Unaudited Pro Forma Condensed Combined Financial Information

 

Basis of Pro Forma Presentation

 

On December 22, 2015, PositiveID Corporation (“PositiveID” or the “Company”) entered into a Stock Purchase Agreement (“Purchase Agreement”) for the purchase of all of the outstanding common stock of E-N-G Mobile Systems, Inc. ( “ENG”) from its sole shareholder (the “Seller”) (the “Acquisition”). The Acquisition was completed on December 24, 2015.

 

Pursuant to the Purchase Agreement, as consideration at the time of closing of the Acquisition, PositiveID paid the Seller Seven Hundred Fifty Thousand Dollars ($750,000) in cash and issued a convertible secured promissory note to the Seller in the amount of One Hundred Fifty Thousand Dollars ($150,000) (the “ENG Note”). Additional earn-out payments may be earned by the Seller as described in the Purchase Agreement. Earn-out payments are estimated to be approximately $111,000, to be paid in the four months following the closing of the acquisition. The Company has also entered into a two year consulting agreement with the Seller.

 

The Company has previously reported, in a current Form 8-K/A dated February 19, 2016, the unaudited pro forma information related to the combination of the Company and its acquisition of Thermomedics, Inc. (“Thermo”). The combined pro forma financial statements of the Company, including Thermo have been used as the basis for making pro forma adjustments to reflect the acquisition of ENG disclosed herein.

 

Under the acquisition method of accounting the total estimated purchase price as described in Note 1 to this unaudited pro forma condensed combined financial information was allocated to the net tangible and intangible assets of ENG acquired and liabilities assumed in connection with the Acquisition based on their estimated fair values. The estimated fair values of certain assets and liabilities have been estimated by management and are subject to change upon the finalization of the fair value assessments.

 

The historical consolidated financial information has been adjusted in the unaudited pro forma condensed combined financial information to give effect to pro forma events that are directly attributable to the acquisition, factually supportable, and, with respect to the statements of operations, expected to have a continuing impact on the combined results. The unaudited pro forma condensed combined financial information does not purport to be indicative of the financial position or results of operations of PositiveID that would have been reported had the Acquisition been completed as of the dates or for such periods presented, nor is it intended to project PositiveID’s future financial position or results of operations. The unaudited pro forma condensed combined financial information and the accompanying notes should be read together with PositiveID’s audited consolidated financial statements and accompanying notes for the year ended December 31, 2014, Management’s Discussion and Analysis included in PositiveID’s Annual Report on Form 10-K for the year ended December 31, 2014, from the Current Report on Form 8-K/A filed on February 19, 2016, and from ENG’s audited financial statements and accompanying notes for the year ended December 31, 2014 included in Exhibit 99.1 of this Current Report.

 

The unaudited pro forma condensed combined financial information as of and for the nine months ended September 30, 2015 has been prepared from PositiveID’s unaudited condensed consolidated financial statements included in PositiveID’s Quarterly Report on Form 10-Q as of and for the nine months ended September 30, 2015, from the Current Report on Form 8-K/A filed on February 19, 2016, and from the unaudited financial statements of ENG as of and for the nine months ended September 30, 2015 included in Exhibit 99.2 of this Current Report.

 

The unaudited pro forma condensed combined balance sheet as of September 30, 2015 has been prepared to present PositiveID’s financial position as if the Acquisition had occurred on September 30, 2015. The unaudited pro forma condensed combined statements of operations for the year ended December 31, 2014 and for the nine months ended September 30, 2015 have been prepared to present PositiveID’s results of operations as if the Acquisition had occurred on January 1, 2014 and January 1, 2015, respectively.

 

The unaudited pro forma adjustments are based on preliminary estimates, available information and certain assumptions, which may be revised as additional information becomes available. The unaudited pro forma condensed combined financial information does not reflect any adjustments for nonrecurring items or anticipated synergies resulting from the Acquisition.

 

   
  

 

 PositiveID Corporation

Pro Forma Unaudited Condensed Combined Balance Sheet

As of September 30, 2015

(in thousands)

 

   PositiveID Corporation Historical (a)   Thermomedics Inc. Historical (a)   Pro Forma Adjustments (a)   Pro Forma Combined (a)   ENG Mobile Systems, Inc. Historical   Pro Forma Adjustments (ENG)   Pro Forma Combined 
Assets                                   
Current assets:                                   
Cash and cash equivalents  $319   $10  $(185)  $144   $994    $ (893)(b)(c)(f)  $245 
Accounts receivable, net   -    8    1    9    29    607(b)   645 
Inventory   -    31    (15)   16    1,648    (399)(b)   1,265 
Prepaid expenses and other   39    -    -    39    5    28(b)   72 
Total current assets   358    49    (199)   208    2,676    (657)   2,227 
Property and equipment, net   3    10    (2)   11    29    94(b)   134 
Goodwill   510    -    513    1,023    -    -    1,023 
Intangibles   164    -    200    364    -    211(d)   575 
Other assets   11    6    (6)   11    7    95(b)(c)   113 
Total assets  $1,046   $65  $506   $1,617   $2,712   $(257)  $4,072 
                                    
Liabilities and Stockholders’ Equity                                   
Current Liabilities:                                   
Accounts payable  $118   $64 $(32)  $150   $256   $(132)(b)  $274 
Accrued expenses   879    1    116    996    123    (12)(b)   1,107 
Notes payable   429    -    -    429    14    (13)(b)   430 
Deferred revenue   -    -    -    -    1,683    (477)(b)   1,206 
Contingent purchase price                            111(e)   111 
Due to parent   -    2,463    (2,463)   -    -    -    - 
Short-term convertible debt and accrued interest, net of discounts and premiums   1,488    -    75    1,563    -     902(c)(f)    2,465 
Embedded conversion option liability   5,823    -    -    5,823    -    -    5,823 
Total current liabilities   8,737    2,528    (2,304)   8,961    2,076    379    11,416 
                                    
Long-term liabilities                                   
Contingent purchase price   -    -    184    184    -    -    184 
Mandatorily redeemable preferred stock, Series I   2,132    -    -    2,132    -    -    2,132 
Total liabilities   10,869    2,528    (2,120)   11,277    2,076    379    13,732 
                                    
Stockholders’ equity (deficit):                                   
Preferred stock, Series J   -    -    163    163    -    -    163 
Common stock   3,766    -    -    3,766    -    -    3,766 
Additional paid – in capital   126,054    -    -    126,054    -    -    126,054 
Retained earnings/Accumulated deficit   (139,643)   (2,463)   2,463    (139,643)   636    (636)(b)   (139,643)
Total stockholders’ equity (deficit)   (9,823)   (2,463)   2,626    (9,660)   636    (636)   (9,660)
Total liabilities and stockholders’ equity  $1,046   $65  $506   $1,617   $2,712   $(257)  $4,072 

 

The accompanying notes are an integral part of this pro forma financial information.

 

   
  

 

 PositiveID Corporation

Pro Forma Unaudited Condensed Combined Statement of Operations

For The Nine Months Ended September 30, 2015

(in thousands)

 

   PositiveID Corporation Historical (a)   Thermomedics Inc. Historical (a)   Pro Forma Adjustments (a)   Pro Forma Combined (a)   ENG Mobile Systems, Inc. Historical   Pro Forma Adjustments (ENG)   Pro Forma Combined 
                             
Revenue  $2,682   $415   $-   $3,097   $3,365   $-   $6,462 
Cost of sales   148    66    -    214    2,042    -    2,256 
Gross profit   2,534    349    -    2,883    1,323    -    4,206 
Operating expenses:                                   
General and administrative   3,730    347    90(h)(i)   4,167    1,127    112(g)(h)   5,406 
Research and development   992    -    -    992    -    -    992 
Total operating expenses   4,722    347    90    5,159    1,127    112    6,398 
Operating income (loss)   (2,188)   2    (90)   (2,276)   196    (112)   (2,192)
Other (income)/expense                                   
Interest expense   (3,389)   -    -    (3,389)   (1)   (87)(i)   (3,477)
Change in fair value of embedded conversion option liability   (1,446)   -    -    (1,446)   -    -    (1,446)
Loss on extinguishment of debt   (233)   -    -    (233)   -    -    (233)
Other income (expense), net   370    -    -    370    (1)   -    369 
Total interest and other income (expense), net   (4,698)   -    -    (4,698)   (2)   (87)   (4,787)
Net income (loss)  $(6,886)  $2   $(90)  $(6,974)  $194   $(199)  $(6,979)
Loss per common share - basic and diluted:  $(0.03)            $(0.03)   -    -   $(0.03)
Shares used in computing net loss per share - basic and diluted   271,531         -    271,531    -    -    271,531 

 

The accompanying notes are an integral part of this pro forma financial information.

 

   
  

 

 PositiveID Corporation

Pro Forma Unaudited Condensed Combined Statement of Operations

For The Year Ended December 31, 2014

(in thousands)

 

   PositiveID Corporation Historical (a)   Thermomedics Inc. Historical (a)   Pro Forma Adjustments(a)   Pro Forma Combined (a)   ENG Mobile Systems, Inc. Historical   Pro Forma Adjustments (ENG)   Pro Forma Combined 
                             
Revenues  $945    677   $-   $1,622   $2,502   $-   $4,124 
Cost of sales   294    131    -    425    1,537     -    1,962 
Gross profit   651    546    -    1,197    965     -    2,162 
Operating expenses:                                   
General and administrative   4,313    494    100    4,907    1,040     126(g)(h)   6,073 
Research and development   588    2    -    590    -    -    590 
Total operating expenses   4,901    496    100    5,497    1,040    126    6,663 
Operating income (loss)   (4,250)   50    (100)   (4,300)   (75)   (126)   (4,501)
Other (income) expense                                   
Interest expense   (3,010)   -    -    (3,010)   (2)   (116)(i)   (3,128)
Changes in contingent earn-out liability   514    -    -    514    -    -    514 
Change in fair value of embedded conversion option liability   (198)   -    -    (198)   -    -    (198)
Loss on extinguishment of debt   (246)   -    -    (246)   -    -    (246)
Other income (expense)   (1)   -    -    (1)   (1)   -    (2)
Total costs and expenses   (2,941)   -    -    (2,941)   (3)   (116)   (3,060)
Net income (loss) before provision for income taxes   (7,191)   50    -    (7,241)   (78)   (242)   (7,561)
Provision for income taxes   -    -    -    -    -    -    - 
Net income (loss)  $(7,191)  $50   $(100)  $(7,241)  $(78)  $(242)  $(7,561)
Net loss per common share  $(0.07)            $(0.07)  $-   $-   $(0.08)
Shares used in computing net loss per share - basic and diluted   96,602         -    96,602    -    -    96,602 

 

The accompanying notes are an integral part of this pro forma financial information.

 

   
  

 

PositiveID Corporation

Notes to Pro Forma Condensed Combined Financial Information

(Unaudited)

 

Note 1. Acquisition of E-N-G Mobile Systems, Inc.

 

On December 24, 2015, PositiveID Corporation (“PositiveID” or “Company”) acquired all of the outstanding common stock of E-N-G Mobile Systems, Inc. (“ENG”) from its sole shareholder (the “Seller”). Pursuant to the Purchase Agreement, as consideration at the time of closing of the Acquisition, PositiveID paid the Seller Seven Hundred Fifty Thousand Dollars ($750,000) in cash and issued a convertible secured promissory note to the Seller in the amount of One Hundred Fifty Thousand Dollars ($150,000) (the “ENG Note”). Additional earn-out payments may be earned by the Seller as described in the Purchase Agreement. Earn-out payments are estimated to be approximately $111,000, to be paid in the four months following the closing of the acquisition. The Company has also entered into a two year consulting agreement with the Seller.

 

The estimated purchase price of the acquisition totaled $909 thousand, comprised of $750 thousand in cash, a convertible seller note of $150 thousand, the fair value of the contingent consideration estimated at approximately $111 thousand, net of an estimated recovery based on the closing net worth of ENG, estimated at $102 thousand. The fair value of the contingent consideration was estimated based upon the present value of the expected future payouts of the contingent consideration and is subject to change upon the finalization of the purchase accounting.

 

Under the acquisition method of accounting, the estimated purchase price of the Acquisition was allocated to ENG’s net tangible and identifiable intangible assets and liabilities assumed based on their estimated fair values as of the date of the completion of the Acquisition, as described in the introduction to this unaudited pro forma condensed combined financial information, as follows:

 

(in thousands)

 

Assets Acquired:     
Cash  $99 
Accounts receivable   636 
Inventory   1,249 
Other assets   33 
Property and equipment, net   123 
Customer relationships   211 
    2,351 
Liabilities assumed:     
Accounts payable and accrued expenses   236 
Deferred revenue   1,206 
    1,442 
Total estimated purchase price  $909 

 

   
  

 

Note 2. Pro Forma Adjustments

 

The pro forma adjustments included in the unaudited pro forma condensed combined financial information are as follows:

 

  (a)

The balances, adjustments and disclosures related to the acquisition of Thermomedics, Inc. are included in the Form 8-K/A filed by the Company on February 19, 2016.

     
  (b) To record the entry necessary to adjust the tangible assets and liabilities of E-N-G Mobile Systems, Inc. to their estimated fair values at the time of the acquisition.
     
  (c) To record the purchase price of $750 thousand in cash and a convertible note payable of $150 thousand, net of an estimated recovery based on the closing net worth of ENG, estimated at $102 thousand.
     
  (d) To reflect the preliminary estimate of the fair value of amortizable intangible assets acquired, consisting of customer relationships.
     
  (e) To record a liability for the estimated fair value of the contingent consideration.
     
  (f) To record a convertible note with a principal value of $902 thousand (the “Financing Note”) used to finance the cash component of the purchase price. The amount recoded, $752 thousand, is net of original issue discount, fees, legal and diligence costs.
     
  (g) To expense the direct costs of the acquisition comprised of legal, due diligence, and accounting services of $70 thousand.
     
  (h) To record amortization of customer lists over an estimated 5-year useful life.
     
  (i) To record interest expense related to the Seller convertible note and the Financing Note.